Samples Procurement for Colorectal Cancer, Gastric Cancer, and Non-malignant Disease

Last updated: April 28, 2022
Sponsor: Renmin Hospital of Wuhan University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Colon Cancer; Rectal Cancer

Ulcers

Rectal Cancer

Treatment

N/A

Clinical Study ID

NCT03972956
SAMPGICUS
  • Ages 18-80
  • All Genders

Study Summary

The purposes of this study are to collect and store samples including blood, normal and tumor tissue from patients with colorectal cancer or gastric cancer, to collect and store samples including blood and/or normal gastrointestinal tissue (if available) from patients with non-malignant disease (including, but not limited to, inflammatory bowel disease (IBD), gastric ulcer, hemorrhoids or hernia), and to create a database for the collected samples and allow access to relevant clinical information for current and future protocols.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Any patient diagnosed with colorectal cancer, gastric cancer, non-malignant diseasethat requires undergoing surgery.
  • Must be willing and able to provide informed consent.

Exclusion

Exclusion Criteria:

  • Subjects whose comorbidities would preclude diagnostic or therapeutic intervention.

Study Design

Total Participants: 1000
Study Start date:
December 23, 2020
Estimated Completion Date:
December 23, 2026

Connect with a study center

  • Department of Gastrointestinal Surgery II, Renmin Hospital of Wuhan University

    Wuhan, Hubei 430060
    China

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.